Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 23
Selected: 0
NCT IDTitle
NCT00408226Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
NCT01639248Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
NCT00400348Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
NCT00806065Study of ENMD-2076 in Patients With Multiple Myeloma
NCT00306631A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
NCT05438394Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM
NCT02234986A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
NCT07017725A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
NCT00481455Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
NCT00444314Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
NCT00568646Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
NCT00506402A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
NCT00592579A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
NCT00394810Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
NCT00049790Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer
NCT00904787Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies
NCT01104675Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
NCT00306618Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
NCT00607607A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
NCT00658671A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
NCT04758767CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
NCT00328497A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
NCT00656461Phase 1 Study of MKC-1 in Patients With Advanced Cancer